Leicester patients have not had to wait long to hear about the next big development in weight loss treatment. Foundayo, the brand name for orforglipron, was authorised by the Medicines and Healthcare products Regulatory Agency on 10 August 2026, making the UK the first country in Europe to approve this once-daily GLP-1 weight loss tablet. …
At Everest Pharmacy, we regularly speak with patients who have looked into NHS weight management support, only to find themselves stuck on a waiting list, unsure of their eligibility, or limited in which treatments are actually available to them locally. The NHS plays a vital role in weight management care, but it is not always …
At Everest Pharmacy, we often hear from people who have checked their BMI online, seen a number above or below 30, and assumed that single figure decides everything about their eligibility for weight loss medication. It is an understandable assumption, but it is not quite how eligibility actually works in practice. Through our sister site, …
GLP-1 medications such as semaglutide and tirzepatide have become some of the most talked-about treatments in weight management, and it is easy to see why. But with demand outpacing supply in some areas, a growing number of people are turning to the internet to find quicker or cheaper ways to get hold of these medicines. …